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http://dx.doi.org/10.1016/j.cmet.2014.02.002The sterol regulatory element binding
protein-1a (SREBP-1a) is a lipogenic
transcription factor that differentially reg-
ulates the expression of inflammation-
related genes. One of themost profoundly
downregulated genes in Srebp-1a-defi-
cient mice was recently reported to be
the inflammasome sensor Nlrp1a (Im
et al., 2011). We obtained Srebp-1a-
deficient mice to cross with mice con-
taining an Nlrp1a activating mutation to
see if the Srebp-1a deficiency could
reduce the incidence of their spontaneous
inflammatory disease (Masters et al.,
2012). We noticed while breeding the
Srebp-1a/Nlrp1a mutant mice that no
pups in any of the first litters had
both Srebp-1a deleted and Nlrp1a
mutated on the same allele. This sug-
gested that the genes are in close
proximity, and not recombining. Indeed,
Srebp-1a is on chromosome 11: 60, 209,
846, and Nlrp1a is next door at chromo-
some 11: 71, 117, 950.
This drew our attention to the fact that
the original ES cells used to create
Srebp-1a-deficient mice were from the
129/Ola strain. We and others have previ-
ously shown that in all 129 strains of mice
so far tested, Nlrp1a is not expressed
(Sastalla et al., 2013). We therefore geno-
typed theNlrp1 locus using strain-specific
primers for Nlrp1b, which distinguish
129/Ola from C57BL/6, and confirmed
that in Srebp-1a-deficient mice the Nlrp1
locus is from the parental 129/Ola ES
cell, not fully backcrossed to C57BL/6
(Figure S1A, lane 2). After considerable
effort, we generated Srebp-1a-deficient
mice, where the Nlrp1 locus is from
C57BL/6, not 129/Ola (Figure S1A, lane
4). We find that in this backcrossed line
of C57BL/6 Srebp-1a/ mice, Nlrp1a
expression is now normal (Figure S1B).
Genetic activation of NLRP1a triggers
inflammasome formation and IL-1b pro-
duction; however, stimuli that trigger
NLRP1a are not yet known (Masterset al., 2012). The Osborne laboratory (Im
et al., 2011) reported that IL-1b produc-
tion from Srebp-1a/ BMDM was
reduced when stimulated by LPS+ATP,
which is unusual as this treatment is
known to activate NLRP3, not NLRP1
(Kovarova et al., 2012). Indeed, we veri-
fied that IL-1b production from NLRP3-
deficient cells treated with LPS+ATP
was absent; however, macrophages
from Srebp-1a/ mice, or backcrossed
C57BL/6 Srebp-1a/ mice, had normal
IL-1b production when stimulated with
LPS, LPS+ATP (NLRP3 activation), or
LPS+poly dAdT (AIM2 activation)
(Figure S1C).
The region of chromosome 11 where
Srebp-1a is situated is quite gene
dense, and so strain differences in
nearby alleles may account for some of
the other observations made with these
mice. For example, in a microarray study
of liver tissue, two of the five most differ-
entially expressed genes (Atox1 and
Ulk2) are in this region (Im et al., 2009).
A second microarray study found that
Centb1, Grap, Ccl8, and St6galnac1
are also differentially expressed, and
these are near Srebp-1a, as well (Im
et al., 2011).
It is still possible that Srebp-1a can
bind to the Nlrp1a promoter, as shown in
the 2011 paper by Osborne and col-
leagues (Im et al., 2011), so our results
are not directly contradictory. Moreover,
the loss of a transcription factor such as
Srebp-1a could have context-dependent
effects on Nlrp1a expression that we
have not investigated. However, the
more fully backcrossed Srebp-1a-defi-
cient mice we generated, with Nlrp1a
inherited from the C57BL/6 strain, clearly
show that Nlrp1a expression is unaltered
at baseline in macrophages and that
IL-1b production from these macro-
phages is also normal following inflam-
masome activation. Future studies of
Srebp-1a/ mice should ensure that theCell Metabolismphenotype of interest is not due to in-
sufficient backcrossing, and the mice we
have generated will be useful in this
endeavor.
Similar caution is warranted in the
study of mice knocked out for any gene
in the vicinity of the Nlrp1 cluster on chro-
mosome 11. As an example, our labora-
tories have genotyping data indicating
that the iNOS knockout mice provided
by Taconic Farms through mid-2005
carried an Nlrp1 locus inherited from the
129 mouse, while the knockout from
Jackson Laboratories carried an Nlrp1
locus inherited from the C57BL/6 strain.
Discrepancies in findings between iNOS
knockout mice across various labora-
tories may be linked to differences in
this region of chromosome 11. Another
example with implications for the meta-
bolism community is mice lacking arach-
idonate 15-lipoxygenase (ALOX15). The
Nlrp1 locus in these mice is from the
parental 129 ES cell and will be difficult
to backcross as ALOX15 is only 600 kb
away.
Together with critical differences that
inactivate caspase-11 in the 129 mouse
and impact on analyses of caspase-1-
deficient mice (Kayagaki et al., 2011),
our findings emphasize the importance
of genetic fidelity in the analysis of
mouse phenotypes, especially those
that are inflammatory or metabolic in
nature.
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http://dx.doi.org/10.1016/j.cmet.2014.02.016Gerlic et al. contacted us a few months
ago regarding the concerns expressed in
the accompanying letter. We have
communicated with them about their
observations relative to conclusions from
our original paper (Im et al., 2011) and
for the field moving forward. Based
on their data, we performed a sepa-
rate DNA sequence analysis of the
Nlrp1a locus in our SREBP-1a-deficient
(SREBP-1aDF) mice and confirmed that
it is derived from the 129 strain. However,
the issues raised by this observation are
almost certainly more complicated than
the tight linkage between the Srebf1 and
Nlrp1a loci and the extent of backcross-
ing. In fact, similar complications could
affect observations regarding Nlrp1a
function from another recent report from
Gerlic and colleagues (Masters et al.,
2012). In this study, the Nlrp1a locus
from the C57BL/6 strain, a line where
Nlrp1a and Nlrp1c are expressed in
bone marrow-derived macrophages
(BMDMs), was inserted into the BALB/c
strain where Nlrp1a/Nlrp1c also appear
to be silent in BMDMs (similar to the 129
strain).
In addition to this study, there are
numerous publications that suggest that
strain differences at the murine Nrlp1
locus significantly influence responses
to pathogens and inflammatory stimuli.However, a major relevant issue that
has not been solved is why the Nlrp1a lo-
cus in the 129 strain, and several others,
including BALB/c, seems to be silenced
at least in BMDMs cultured in vitro.
To begin to address this issue, we
compared the Nlrp1a DNA sequence
and putative mRNA coding regions from
the C57BL/6 and 129 strains (Figure S1).
The alignment predicts almost complete
identity at the protein level between the
two strains, with the exception of only
two amino acid differences, both of
which correspond to residues that
display variations between different
mouse strains (Sastalla et al., 2013).
Interestingly, the Nlrp1a 50-flanking
sequences from the two strains are
even more highly conserved. The exten-
sive conservation strongly suggests that
the Nlrp1a coding sequence is intact in
both strains and that major structural
alterations surrounding the Nlrp1a gene
are an unlikely explanation for the
absence of Nlrp1a expression in 129
BMDM. This is important because it
suggests the Nlrp1a locus is under evolu-
tionary pressure to maintain the coding
integrity and thus predicts that it is
expressed under the appropriate circum-
stances in 129 mice, we would argue in
response to SREBP-1a activation. Also,
it should be noted that the absenceof 129-derived Nlrp1a transcripts in
cultured macrophages is not reflective
of Nlrp1a expression in an in vivo context
where the SREBP-1aDF mice exhibit a
profound inflammatory phenotype (Im
et al., 2011).
The data in Figures 5 and 6 of our orig-
inal paper demonstrate that Nlrp1a is
directly activated by SREBP-1a because
reintroduction of SREBP-1a into the
SREBP-1aDF macrophages through
either adenovirus vector delivery or
plasmid transfection activates Nlrp1a
mRNA expression and restores LPS-
dependent IL-1b secretion to wild-type
levels (Im et al., 2011). We recently
repeated the activation experiment with
identical results. These observations
demonstrate that the Nlrp1a locus in the
SREBP-1aDF strain can be expressed in
isolated macrophages when SREBP-1a
is reintroduced. Why Nlrp1a is not ex-
pressed in 129 BMDMs as well as from
several other strains is an intriguing issue,
one that deserves more investigation.
Similarly, why further backcrossing to
the C57BL/6 strain (which would alter
many loci on chromosome 11 and else-
where throughout the genome) would
restore Nlrp1a expression deserves
more study as well.
With regard to a second issue, IL-1b
secretion, data in our original paper
